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Background. Brain ischemia initiates series of biochemical reactions that could, di-
rectly or indirectly, induce and extend processes that damage numerous cellular and
subcellular structures. One of the reactions of organism to ischemia is the increased
release of glucocorticoid hormones, included in regulation of effects of numerous me-
diators/modulators that could be released in the acute phase of brain ischemia. Con-
sidering that brain infarction induced systemic response of organism to stress, we pre-
sumed that it reflected the contents of cortisol in the cerebrospinal fluid (CSF) during
the acute phase of the disease, and that cortisol influenced damaging processes of lipid
peroxidation in CNS initiated by ischemia. The aim of our investigation was to define
temporal dynamics and manner correlation of cortisol concentration and index of lipid
peroxidation (ILP) in the CSF patients in the acute phase of completed stroke. Meth-
ods. In this investigation we followed changes of cortisol concentration and ILP in the
CSF of 53 patients in the acute phase of completed stroke. Control group included 14
age and sex matched  patients, subjected to diagnostic lumbar radiculography because
of the sudden motor deficiency onset, without disturbances in the CSF passage and
without pain and the consequences of anti-pain and anti-inflammatory therapy. From
the perspective of the duration of period after an ischemic episode patients were di-
vided into four groups: group A: 0−6 hours (n=12), group B: 7−12 hours (n=14),
group C: 13−24 hours (n=14), and group D: 24−48 hours of postischemic period
(n=13). Concentration of cortisol in the CSF was measured by quantitative RIA
method (Cortisol Bridge kit, Biodata). The ILP was determined according to the spec-
trophotometric method. Results. Concentration of cortisol in the CSF of patients with
completed stroke was of amount 69 ± 6.7 pmol/ml CSF and was significantly increased
(p<0.001) compared to the values of the control group (2.49 ± 0.29 pmol/ml CSF).
From 0 to 6 hours after the ischemic insults concentration of cortisol in the CSF the
amount was 15.9 ± 2.4 pmol/ml CSF (p<0.001), then was progressively increasing and
was maximal from 13 to 24 hours after insults (123.2 ± 7.1 pmol/ml CSF), (p<0.001).
In patients with completed stroke ILP in the CSF was twice increased in the course of
48 hours compared to controls (0.54 ± 0.08 nmolMDA/ml CSF), (p<0.05). By com-
paring the observed parameters we found significant negative correlation between this
two indicators in period from 7 to 24 hours (r=-0.77), (p<0.001). Conclusion. The
main potentially protective effect of the increased CSF cortisol concentration in pa-
tients with completed stroke in the acute phase could be the decrease of deleterious
effects of lipid peroxidation reactions induced by ischemia. This mechanism could be
the attempt of organism to compensate ischemia-disturbed homeostasis.
K e y   w o r d s :  brain ischemia; brain infarction; cerebrospinal fluid;
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Introduction
Brain ischemia, as a powerful stressogenic factor, in-
duces series of organism defensive mechanisms which have
the common aim to protect the disturbed homeostasis (1, 2).
As well as the local brain ischemic damage, brain infarction
also includes systemic changes which represent general re-
sponse of organism to stress (1, 3).
The mechanisms that include the reaction of organism
to stress, are the powerful and almost immediate activation
of regulatory hypothalamus-hypophysis-adrenal cortex-axis
(HHA-axis), with consequently increased release of gluco-
corticoid hormones in blood. The increased necessity of or-
ganism for glucocorticoids was especially expressed in the
acute period of stress (4−6). Cortisol was included in regu-
lation of numerous mediators/modulators effects that could
be released in stress, and thus influenced the quality of or-
ganism responses (7).
Glucocorticoid hormones showed various effects on
CNS. It was shown that they made changes in synthesis or
degradation of numerous cell proteins induced by glucocor-
ticoids (5, 8, 9). Glucocorticoids also participated in regula-
tion of maturation and differentiation of the cells in CNS, as
well as in the modulation of electrophysiological activity,
neuronal transmission, metabolism of biogenic amines and
neuropeptides (8, 10, 11).
More than 95% of total glucocorticoid effects was at-
tributed to cortisol, which was mostly present in blood as a
bound form (12, 13). The importance of glucocorticoid
hormones and their presence in CSF in different pathologi-
cal circumstances in CNS have still not been sufficiently
explained.
Some investigations clearly showed the increased activ-
ity of HHA-axis in the early phase of ischemic insult, as well
as the existence of significantly negative correlation between
the activity of HHA-axis and relative distance of injury (in-
farction) from the brain frontal lobus (14, 15). It was assumed
that frontal injuries led to the disturbed balance between bio-
genic amines and cortisol systems, considering that biogenic
amines (noradrenaline at the first place) regulated the deliver
of releasing factors for corticosteroids (4, 16).
In the course of the acute ischemic insult patients were
frequently exposed to the repeated stress (various cardio-
vascular complications, infections, emotional reactions,
etc.). Repeated stress enhanced the magnitude of adrenal
cortex sensibility for ACTH, and in this way prolonged the
circumstances for hypercorticism (15, 17, 18). This pro-
longed extreme hypercorticism potentiated series of nega-
tive consequences on metabolism, cardiovascular and im-
mune systems. High lethality rate was registered in patients
with extreme values of cortisol in plasma and catechol-
amines in urine (19−22).
Numerous studies demonstrated that glucocorticoids in
brain inhibited rising, releasing or activity of many media-
tors which induced the damage of blood vessels endothe-
lium and rising edema (2, 7, 12, 23−25). It was also shown
that glucocorticoids inhibited formation of prostaglandins
and leukotriens by inhibiting ciklooxygenase and lipooxy-
genase pathways, and inducing the inhibition of phospholi-
pase A2 in cells (2, 12, 22−27). Glucocorticoids showed this
effect by the synthesis induction of protein inhibitors of
phospholipase A2 in cells (12, 27). Certain studies showed
that glucocorticoids inhibited lavage of proteins through en-
dothelium, not only by suppressing vasodilatative mediators
(prostaglandins, bradiquinins, histamins, etc.), but also by
decreasing micro-vascular permeability through induction
of synthesis of corresponding protein inhibitors in endothe-
lial cells (2, 25−28). Glucocorticoids probably had the role
of free radicals scavengers and thus had improved cells sur-
vival and decreased brain swelling (5, 23).
Considering that brain infarction induced systemic re-
sponse of organism to stress, we assumed that it reflected
contents of cortisol in the CSF during the acute phase of
disease, as well as the cortisol-influenced damaging proc-
esses of lipid peroxidation in CNS, initiated by ischemia.
The aim of our investigation was to define temporal dy-
namics and correlation of cortisol concentration and index
of lipid peroxidation in the CSF patients with the acute
phase of completed stroke.
Methods
Investigation included 53 patients of both sexes with
completed stoke, between the ages of 55 and 70. These pa-
tients were under no therapy at the moment of samples col-
lection. Completed stroke was confirmed by CT scan.
From the perspective of the period of duration after an
ischemic episode patients were divided into four groups: 1)
0−6 hours (n=12); 2) 7−12 hours (n=14); 3) 13−24 hours
(n=14); and 4) 24−48 hours of postischemic period (n=13).
Control group included 14 patients age and sex
matched, subjected to diagnostic lumbar radiculography
with sudden onset of motor deficiency, without disturbances
in the CSF passage, without therapy and with no symptoms
and signs of the acute inflammatory, neurodegenerative or
psychiatric diseases.
Samples of CSF (1 ml) were collected by lumbar punc-
tion in the period from 8 to 10 hours in the morning in plastic
tubes and were frozen until the appropriate biochemical
analysis. Concentration of cortisol in the CSF was measured
by quantitative RIA method (Cortisol Bridge kit, Biodata).
Index of lipid peroxidation (ILP) was determined ac-
cording to the method of Andreeva, et al. (29) after stimu-
lation of lipid peroxidation in vitro with Fe-salts. Thiobar-
bituric acid reacted with malondyaldehyde (MDA), which
originated from polyunsaturated fatty acids in the process of
lipid peroxidation, and formed a colored complex. Concen-
tration of generated MDA was measured spectropho-
tometrically on 533 nm.
All the values were presented as the mean value ±
standard error (SE). Student's t-test for the independent
samples was used for the evaluation of statistical differencesБрој 5 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Страна 487
between the examined parameters. Correlation between sin-
gle measured parameters was determined by measurement
of regression correlation coefficient.
Results
Concentration of cortisol in the CSF of patients with
completed stroke was 69 ± 6.7 pmol/ml CSF and was sig-
nificantly increased (p<0.001) compared to the values of the
control group (2.49 ± 0.29 pmol/ml CSF) (Fig. 1). From 0
to 6 hours after the ischemic insults concentration of corti-
sol in the CSF was 15.9 ± 2.4 pmol/ml CSF (p<0.001), then
was progressively increasing and reached maximal values
from 13 to 24 hours after the insults (123.2 ± 7.1 pmol/ml
CSF), (p<0.001) (Fig. 1).
Index of lipid peroxidation in the CSF was increased
twofold in patients with completed stroke in the course of
48 hours, compared to controls (0.54 ± 0.08 nmol MDA/ml
CSF), (p<0.05) (Fig. 2). Follow up of temporal dynamics of
ILP in the CSF of stroke patients was the least increased in
the group from 0 to 6 hours after ischemia (0.74 ± 0.07
nmol MDA/ml CSF), (p<0.05), but was gradually increas-
ing in the other groups and in the group from 25 to 48 hours
after ischemia was 1.89 ± 0.26 nmol MDA/ml CSF (Fig. 2).
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Fig. 1 − Concentration of cortisol in the CSF of patients with completed stroke. Values are
given as pmol/ml CSF. Mean ± SE
* - Student's t-test, p< 0.001.
Total - average value of all patients with completed stroke;
Control - concentration in the control group.
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Fig. 2 − Index of lipid peroxidation in the CSF of patients with completed stroke. Values are
given as nmol MDA/ml CSF. Mean ± SE
* - Student's t-test, p< 0.05.
Total - average value of all patients with completed stroke;
Control - value in the control group.Страна 488 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Број 5
Comparing the observed results significant negative
correlation was found between the concentration of cortisol
and values of ILP in the CSF in period from 7 to 24 hours
after insults (r=-0.77, p<0.001) (Fig. 3).           
Discussion
Ischemic lesions in CNS are pathological basis for
neuronal cell damage and comprise activation of diverse
mediator systems and homeostatic responses. Brain is-
chemia triggers a cascade of free radical reactions, caus-
ing structural and functional damage of biomolecules,
disturbances in intracellular metabolism, as well as the
damage of the adaptive response capabilities, all resulting
in neuronal cell death (30, 31). It is known that the in-
creased production of active oxygen species in the fore-
brain cortex and striatum is present in the early stage of
brain ischemia. This process leads to chain reaction of
free radical propagation, increase in superoxide an-
ion/superoxide dismutasa ratio, and the decreased activity
of glutathione reductase. Thus it is suggesting the insuffi-
cient function of antioxidative defense system for super-
oxide anion and hydrogen peroxide removal, as well as
for removal of other peroxides formed in reactions of re-
active oxygen species and biomolecules (32, 33).
Lipid peroxidation, as a consequence of free radical
reaction, causes damage to cell membranes and their
function. Our results indicated that the index of lipid per-
oxidation in the CSF of patients with completed stroke in-
creased progressively during first 48 hours. Amplification
and propagation of lipid peroxidation during the acute pe-
riod of completed stroke were also observed. Conse-
quences of these toxic reactions were alterations in cell
membrane permeability and neurotransmitter receptor
presentation, disturbance of cell membrane function and
integrity, accompanied with malfunction of membrane en-
zymes and extracellular/intracellular communications (34).
Degradation of cell membrane phospholipids increased
the level of free fatty acids, above all the arachidonic acid
(35, 36). Clinical studies, including patients with the acute
brain infarction, demonstrated significant rise of PGF2α and
PGE2 content in CSF, and the increase of peroxidation
products, originated mostly during arachidonic acids cas-
cade (37). Application of selective enzyme blockaders in
arachidonic acids cascade decreased brain edema and pro-
tected neurons in certain regions of brain from ischemic
damage (36, 38). To a certain extent, these effects were
caused by the decreased production of free radicals in
arachidonic acids cascade (36, 38).
Integrity of cellular and subcellular membranes was
the fundamental assumption for normal activity and pre-
vention of irreversible functional and structural damage of
neurons. The increased release of glucocorticoids was one
of the initiated protective mechanisms during the acute
brain infarction. The level of cortisol in CSF of patients
with the acute brain infarction was about 28 times higher
compared to the control group, with the peak values meas-
ured 13−24 hours after ischemia.
Some experimental studies indicated that glucocorti-
coid hormones inhibited the process of lipid peroxidation in
all brain structures (2, 27, 39, 40). It was also shown that
the application of glucocorticoid hormones immediately be-
fore unilateral carotid ligation prevented ischemic alteration
of EEG activity and decreased brain edema (21, 39). Fur-
thermore, the application of glucocorticoid hormones after
the experimental cardiac arrest led to recovery of normal
ECG activity, the increase of Na
+, K
+, ATPase activity and
clinical recovery (21, 39). The results of other studies indi-
cated glucocorticoid-induced reduction of free radical and
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lipid peroxide formation in all brain structures, as well as
the increased activity of neuronal Na
+, K
+, ATPase during
the early phase of brain concussion and subarachnoid hem-
orrhage (21, 41, 42). Our results indicated the presence of
inverse linear correlation between the concentration of cor-
tisol and the index of lipid peroxidation in CSF of patients
with the acute brain infarction 7−24 hours after the insult
(r=-0.77, p<0.001). The increased level of cortisol in CSF
of patients with brain infarction during the acute period
probably represented one of protective responses, aiming to
restrain destructive effects of lipid peroxidation reaction
triggered by ischemia.
Although the mechanisms of glucocorticoid-induced
suppression of lipid peroxidation process have not still been
well understood, it was assumed that it included the inhibi-
tion of dien formation (intermediary product during the pro-
cess of lipid peroxidation) and physical interaction with cell
membrane, preventing spreading of lipid peroxidation chain
reaction (39, 40). Glucocorticoids probably reduced the
process of lipid peroxidation by stabilizing cell membrane,
thus protecting Na
+, K
+, ATPase activity, reducing the dam-
age of mitochondrial membranes and preserving electro-
chemical ionic gradient, as well as cell energy metabolism
(21, 23, 40, 42). It was also shown that glucocorticoids in-
duce synthesis of phospholipase A2  protein inhibitor, re-
ducing arachidonic acid release and production of prosta-
glandins, leucotriens and toxic hydro-peroxides and endo-
peroxides, released in arachidonic acid cascade (25, 26, 42).
Conclusion
Results obtained in this study indicated that the acute
brain infarction induced numerous pathophysiological proc-
esses and reciprocal defensive mechanisms, reflected as
biochemical changes in the CSF.
Index of lipid peroxidation in the CSF as the indicator
and the consequence of neuronal cell membranes damage
was increasing progressively during the first 48 hours after
the brain infarction.
Concentration of cortisol in the CSF was increased in
the acute phase of brain infarction with maximal values in
period from 13 to 24 hours after the ischemic episode and
the was the indicator of the systemic response degree ex-
pression of organism.
Considering that in the period from 7 to 24 hours after
the brain infarction there was the inverse linear correlation
between the concentration of cortisol and the index of lipid
peroxidation in the CSF, it was assumed that cortisol acted
neuroprotectively in the acute period of brain infarction,
primarly by reducing the disruptive effects of lipid peroxi-
dation reaction.
REFERENCES
1.  Garcia J. Morphology of global cerebral ischemia. Crit
Care Med 1988; 16(10): 979−87.
2.  Korompilias AV, Chen LE, Seaber AV, Urbaniak JR.
Actions of glucocorticosteroids on ischemic-reperfused
muscle and cutaneous tissue. Microsurgery 1996;
17(9): 495−502.
3.  Howard SA, Nakayama AY, Brooke SM, Sapolsky RM.
Glucocorticoid modulation of gp120-induced effects on
calcium-dependent degenerative events in primary hip-
pocampal and cortical cultures. Exp Neurol 1999;
158(1): 164−70.
4.  Axelrod J, Reisine T. Stress hormones: their interaction
and regulation. Science 1984; 224(4648): 452−9.
5.  Pereira B, Bechara EJ, Mendonca JR, Curi R. Super-
oxide dismutase, catalase and glutathione peroxidase
activites in the lymphoid organs and sceletal muscles of
rats treated with dexamethasone. Cell Biochem Funct
1999; 17(1): 15−9.
6.  Ohtsuka A, Kojima H, Ohtani T, Hayashi K. Vitamin E re-
duces glucocorticoid-induced oxidative stress in rat skeletal
muscle. J Nutr Sci Vitaminol 1988; 44(6): 779−86.
7.  Munck A, Guyre P, Holbrook N. Physiological func-
tions of glucocorticoid in stress and their relation to
pharmacological actions. Endocr Rev 1984; 5(1):
: 25−44.
8.  Meyer J. Biochemical effects of corticosteroids on neu-
ral tissues. Physiol Rev 1985; 65(4): 946−1020.
9.  De la Fuente M, Ferrandez MD, Burgos MS, Soler A,
Prieto A, Miguel J. Immune function in aged women is
improved by ingestions of vitamin C and E. Can J
Physiol Pharmacol 1988; 76(4): 373−80.
10.  McEwen BS, De Kloet ER, Rostene WH. Adrenal ster-
oid receptors and actions in the nervous system.
Physiol Rev 1985; 66: 1121−88.
11.  Schumacher M, McEwen B. Steroid and barbiturate
modulation of the GABAa receptor. Possible mecha-
nisms. Mol Neurobiol 1989; 3(4): 275−304.
12.  Bowen D, Fauci A. Adrenal corticosteroids. In: Gallin
JI, Goldstein IM, Snyderman R, editors. Inflammation:
basic principles and clinical corelates. New York: Ra-
ven Press; 1988. p.877−95.
13.  Schlechte J, Hamilton D. The effect of glucocorticoids
on corticosteroid binding globulin. Clin Endocr 1987;
27(2): 197−203.
14.  Uete T, Nishimura S, Olya H, Shimomura T, Tatebaya-
shi Y. Corticosteroid levels in blood and cerebrospinal
fluid in various diseases. J Clin Endocr 1970; 30(2):
: 208−14.
15.  Olsson T, Astrom M, Eriksson S, Forsell A. Hypercorti-
solism revealed by the dexamethasone suppression testСтрана 490 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Број 5
with acute ischemic stroke. Stroke 1989; 20(12):
: 1685−90.
16.  Jackson R, Mysiw J. Abnormal cortisol dynamics after
traumatic brain injury. Am J Physic Med Rehab 1989;
68(1): 18−23.
17.  Sapolsky R, Krey L, McEwen B. Stress down-regulates
corticosterone receptors in a site-specific manner in the
brain. Endocrinology 1984; 114(1): 287−92.
18.  Sapolsky R, Armanini M, Packan D, Sutton S, Plotsky
P. Glucocorticoid feedback inhibition of adrenocorti-
cotropic hormone secretagoge release. J Neuroendocri-
nol 1990; 51(3): 328−36.
19.  Feibel J, Hardy P, Compbell R, Goldstein M, Joynt R.
Prognostic value of the stress response following
stroke. JAMA 1977; 238(13): 1374−6.
20.  Woo E, Ma J, Robinson J, Yu Y. Hyperglycemia is a
stress response in acute stroke. Stroke 1988; 19(11):
: 1359−64.
21.  Shaheen AA, Abd El-Fattah A, Gad MZ. Effect of vari-
ous stressors on the level of lipid peroxide, antioxidants
and Na
+, K(+)-ATPase activity in rat brain. Experientia
1996; 52(4): 336−9.
22.  Neuwelt E, Horaczek A, Pagel M. The effect of steroids
on gentamicin delivery to brain after blood-brain bar-
rier disruption. J Neurosurg 1990; 72(1): 123−6.
23.  Lorris B, Coester H. Effect of steroids on edema and
sodium uptake of the brain during focal ischemia in
rats. Stroke 1990; 21(8): 1199−204.
24.  Rommel T, Bodsch W. Glucocorticoid tretmant of va-
sogenic edema. Acta Neurochir  1988; 43 Suppl:
: 145−8.
25.  Williams T, Yarwod H. Effect of glucocorticoids on
microvascular permeability. Am Rev Respir Dis 1990;
141: S39−43.
26.  Relton J, Strijbos P, O
,Shaughnessy, Carey F, Forder
R, Tilders R, et al. Lipocortin-1 is an endogeneous in-
hibitor of ischemic damage in the rat brain. J Exp Med
1991; 174(4): 305−10.
27.  Carey F, Forder R, Edge M, Greene A, Horan M,
Strijbos P, et al. Lipocortin 1 fragment modifies pyro-
genic actions of cytokines in rats. Am J Physiol 1990;
259: R266−9.
28.  Munck A, Medel D, Smith L, Orti E. Glucocorticoid re-
ceptors and actions. Am Rev Respir Dis 1990; 141:
: S2−10.
29.  Andreeva IL, Kožemjakin AL, Kiskun AA. Modifikacija
metoda opredelenija perekisej lipidov v teste s tiobar-
biturovoj kislotoi. Lab Delo 1988; 11: 41−3.
30.  Halliwell B, Gutteridge JMC. The role of iron in free
radical reactions. In: Hayashi O, Niki E, Kondo M, Yo-
shikawa T, editors. Medical, biochemical and chemical
aspects of free radicals. Amsterdam: Elsevier Science
Publishers BV; 1989. p.21−32.
31.  Sies H. Oxidative stress. In: Sies H, editor.  London:
Academic Press; 1985.
32.  Selaković V. Uticaj ishemičnog oštećenja ekstremiteta
na ishod oksidoreduktivnog stresa izazvanog ishemi-
jom mozga [magistarski rad]. Beograd: Medicinski fa-
kultet; 1992.
33.  Stanimirović D. Oksidoreduktivni stres u ishemičnom
oštećenju neurona [doktorska disertacija]. Beograd:
VMA; 1990.
34.  Villacara A, Kumami K, Yamamoto T, Mršulja BB,
Spatz M. Ischemic modification of cerebrocortical
membranes: 5-hydrxytryptamine receptors, fluidity and
inducible in vitro lipid peroxidation. J Neurochem
1989; 53(2): 595−601.
35.  Demopoulos BH, Flamm SE, Pitronigro DD, Seling-
man LA. The free radical pathology and the microcir-
culation in the major central nervous system disorders.
Acta Physiol Scand 1980; 492 Suppl: 91−119.
36.  Siesjo B. Cell damage in the brain: a speculative sythe-
sis. J Cereb Blood Flow Metab 1981; 1(2): 155−85.
37.  White RP. Cerebrospinal fluid eicosanoids as an index
of cerebrovascular status. Ann NY Acad Sci 1989; 559:
: 131−45.
38.  Chan HP, Longar S, Chan S, Yu A,  Hillerd L, Chu L,
et al. The role of arachidonic acid and oxygen radical
metabolites in pathogenesis of vasogenic edema and
astrocyte swelling. Ann NY Acad Sci 1989; 559:
: 237−47.
39.  Katz L, Vaagenes P, Safar P, Diven W. Brain enzyme
changes as markers of brain damage in rat cardiac ar-
rest model. Effects of corticosteroid therapy. Resusci-
tation 1989; 17(1): 39−53.
40.  Marzatico F, Gaetani P, Buratti E, Messina AL, Fer-
lenga P, Rodriguez Y, et al. Effects of high-dose meth-
ylprednisolone on Na
+, K(+)-ATPase and lipid peroxi-
dation after experimental subarachnoid hemorrhage.
Acta Neurol Scand 1990; 82(4): 263−70.
41.  Hall ED, Braughler JM. Effects of intravenous meth-
ylprednisolone on spinal cord lipid peroxidation and
Na
+, K(+)-ATPase activity. J Neurosurg 1982; 57(2):
: 247−53.
42.  Uenohara H, Imaizumi S, Suzuki J, Yoshimoto T. The
protective effect of mannitol, vitamin E and glucocorti-
coid on ischemic brain injury: evaluation by chemilu-
minescence, energy metabolism and water content.
Neurol Res 1988; 10(4): 194−9.
The paper was recieved on September 10, 2001.Број 5 ВОЈНОСАНИТЕТСКИ ПРЕГЛЕД Страна 491
Apstrakt
Selaković VM, Jovanović MD, Jovičić A. Vojnosanit Pregl 2002; 59(5): 485−491.
PROMENE KONCENTRACIJE HIDROKORTIZONA I INDEKSA LIPIDNE
PEROKSIDACIJE U CEREBROSPINALNOJ TEČNOSTI BOLESNIKA U
AKUTNOJ FAZI INFARKTA MOZGA
Uvod. Ishemija mozga pokreće niz biohemijskih reakcija koje direktno ili indi-
rektno dovode do inicijacije i širenja procesa koji oštećuju mnoge celularne i
subcelularne strukture. U okviru reakcije organizma na ishemiju dolazi do po-
većanog oslobađanja glukokortikoidnih hormona, koji su uključeni u regulaciju
dejstva mnogih medijatora/modulatora koji se oslobađaju u akutnoj fazi ishe-
mije mozga. S obzirom na to da infarkt mozga dovodi do pokretanja sistem-
skog odgovora organizma na stres, pretpostavili smo da se to odražava na sa-
držaj hidrokortizona u cerebrospinalnoj tečnosti (CST) tokom akutne fazi bole-
sti, kao i da hidrokortizon utiče na ishemijom pokrenute oštećujuće procese li-
pidne peroksidacije u CNS-u. Cilj ovog istraživanja je bio da tokom akutne faze
infarkta mozga definišemo vremensku dinamiku promene i karakter povezano-
sti  koncentracije hidrokortizona  i  indeksa lipidne peroksidacije (ILP) u CST.
Metode. U ovom istraživanju praćena je promena koncentracije i ILP u CST
kod 53 bolesnika sa infarktom mozga u akutnoj fazi. Kontrolnu grupu predstav-
ljalo je 14 ispitanika podvrgnutih dijagnostičkoj lumbalnoj radikulografiji zbog
naglog razvoja motornog deficita, bez smetnji u pasaži likvora, koji nisu koristili
antidoloroznu i antiinflamatornu terapiju. Dinamika promene koncentracije hid-
rokortizona i indeksa lipidne peroksidacije  praćena je u CST bolesnika sa
akutnim infarktim mozga, koji su podeljeni u sledeće grupe: A. grupa: 0−6 ča-
sova nakon infarkta mozga (n=12), B. grupa: 7−12 časova nakon infarkta mo-
zga (n=14), C. grupa: 13−24 časa nakon infarkta mozga (n=14) i D. grupa:
25−48  časova nakon infarkta mozga (n=13). Koncentracija hidrokortizona u
CST određivana je kvantitativno, RIA metodom (Cortisol Bridge kit, Biodata).
Indeks lipidne peroksidacije u CST određivan je spektrofotometrijskom meto-
dom. Rezultati. Koncentracija hidrokortizona u CST kod ispitivanih bolesnika
sa akutnim infarktom mozga iznosi 69,0 ± 6,7 pmol/ml CST i statistički značaj-
no je povećana (p<0,001) u odnosu na kontrolu (2,49 ± 0,29 pmol/ml CST). Do
šestog časa nakon insulta koncentracija hidrokortizona u CST iznosi 15,9 ± 2,4
pmol/ml CST (p<0,001), zatim dalje raste i maksimum dostiže 13−24 časa na-
kon insulta (123,2 ± 7,1 pmol/ml) (p<0,001). Kod bolesnika sa infarktom moz-
ga tokom prvih 48 časova izmeren ILP u CST u ovoj studiji iznosi 1,07 ± 0,12
nmol MDA/ml CST, što je statistički značajno povećanje (p<0,05) u odnosu na
vrednost izmerenu u kontrolnoj grupi ispitanika (0,54 ± 0,08 nmol MDA/ml
CST). Dobijeni rezultati pokazuju i statistički značajnu negativnu povezanost
između ova dva pokazatelja u periodu od 7 do 24 časa nakon infarkta mozga
(r=-0,77) (p<0,001). Zaključak. S obzirom da se hidrokortizon oslobađa u okvi-
ru akutne reakcije organizma na stres, to porast njegove koncentracije kod
CST bolesnika u akutnoj fazi infarkta mozga može imati za cilj smanjenje ošte-
ćujućih efekata ishemijom pokrenutih reakcija lipidne peroksidacije i može
predstavljati pokušaj organizma da na taj način kompenzuje narušenu homeo-
stazu.
Kl juč ne reč i :  mozak, ishemija; mozak, infarkt; cerebrospinalna
tečnost; hidrokortizon; lipidi, peroksidacija;
homeostaza.